Screener
EBITDA at other companies
Other financials
Where this comes from
Calculated from Sarepta Therapeutics, Inc.’s reported figures.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
FAQ
- What is Sarepta Therapeutics, Inc.'s EBITDA?
- Sarepta Therapeutics, Inc. (SRPT) reported EBITDA of $23.7M in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s EBITDA changed year-over-year?
- Sarepta Therapeutics, Inc.'s EBITDA decreased by 81.3% year-over-year, from $126.42M to $23.7M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Sarepta Therapeutics, Inc.'s ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude